Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2014
09/30/2014US8846079 Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
09/30/2014US8846078 Brucellosis DNA vaccine
09/30/2014US8846077 High throughput fabrication of nanoparticles
09/30/2014US8846076 Hemostatic sponge
09/30/2014US8846075 Composition material for transmucosal delivery
09/30/2014US8846074 Sublingual films
09/30/2014US8846073 Low temperature processes for making cyclic lipid implants for intraocular use
09/30/2014US8846072 Controlled delivery system
09/30/2014US8846070 Biologically degradable compositions for medical applications
09/30/2014US8846068 Methods and compositions for treating post-operative pain comprising a local anesthetic
09/30/2014US8846066 Methods and related compositions for reduction of fat and skin tightening
09/30/2014US8846064 Cosmetic and pharmaceutical compositions having modified proteins in the form of a supramolecular assembly
09/30/2014US8846062 Reaction product of a polar modified polymer and an alkoxysilane and a composition containing the reaction product
09/30/2014US8846061 Multivitamin-mineral regimens for longevity and wellness
09/30/2014US8846060 Suturable dural and meningeal repair product comprising collagen matrix
09/30/2014US8846059 Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer
09/30/2014US8846044 Stabilizing alkylglycoside compositions and methods thereof
09/30/2014US8846035 Methods for preparing polymer microparticles
09/30/2014US8846026 Composition comprising immunogenic microparticles
09/30/2014US8846019 Use of protoberberines as an active substance regulating the pilosebaceous unit
09/30/2014US8846009 Antimicrobial agents and methods of use
09/30/2014US8846008 Antimicrobial agents and methods of use
09/30/2014US8845612 Methods for iontophoretically treating nausea and migraine
09/30/2014CA2758820C Targeted sustained-release microsphere of vascular occlusive agent containing sodium alginate and sorafenib, production method and use thereof
09/30/2014CA2649361C Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailability
09/30/2014CA2618871C Ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization
09/30/2014CA2576222C Compositions and methods for treating lymphoma
09/30/2014CA2510373C Compounds for oral dosage of active substances requiring a taste masking
09/30/2014CA2356706C Novel exendin agonist formulations and methods of administration thereof
09/26/2014CA2810988A1 Topical gels for use in contact sports
09/25/2014WO2014153541A1 Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
09/25/2014WO2014153384A1 Corticosteroid formulations for the treatment of joint pain and methods of use thereof
09/25/2014WO2014153192A1 Pharmaceutical formulations of chelating agents as a metal removal treatment system
09/25/2014WO2014153163A1 Process for formulating an anionic agent
09/25/2014WO2014153160A2 METHOD OF ENHANCING THE BIODISTRIBUTION AND TISSUE TARGETING PROPERTIES OF THERAPEUTIC CeO2 PARTICLES VIA NANO-ENCAPSULATION AND COATING
09/25/2014WO2014153126A1 Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates
09/25/2014WO2014153038A1 Biocompatible hydrogel polymer matrix for delivery of cells
09/25/2014WO2014152978A1 Equipment assembly and method of processing particles
09/25/2014WO2014152959A1 Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
09/25/2014WO2014152795A2 Cholestosome vesicles for incorporation of molecules into chylomicrons
09/25/2014WO2014152790A1 Chelated drug delivery systems
09/25/2014WO2014152751A1 Multi-layered injectable self-assembling peptide scaffold hydrogels for long-term sustained release of human antibodies
09/25/2014WO2014152661A1 Ocular formulations for drug-delivery to the posterior segment of the eye
09/25/2014WO2014152504A1 Method of treating vitamin b12 deficiency
09/25/2014WO2014152484A1 Freeze dried fecal microbiota for use in fecal microbial transplantation
09/25/2014WO2014152454A1 Transdermal drug delivery system containing rivastigmine
09/25/2014WO2014152450A1 Mesalamine pharmaceutical composition with multiple dosage elements for reduced delivery variability
09/25/2014WO2014152382A1 Transdermal delivery of sildenafil and other phosphodiesterase type 5 inhibitors
09/25/2014WO2014152351A1 Encapsulation of pharmaceuticals for taste masking in chewable tablets
09/25/2014WO2014152338A1 Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
09/25/2014WO2014152296A1 Abuse deterrent solid dosage form for immediate release with functional score
09/25/2014WO2014152280A1 Transdermal formulations of fluticasone
09/25/2014WO2014152269A1 Pharmaceutical soft gelatin capsule dosage form with modified guar gum
09/25/2014WO2014152236A1 Heterocyclic compounds and their uses
09/25/2014WO2014152226A1 Pharmaceutical soft gelatin capsule dosage form
09/25/2014WO2014152207A1 Hot melt granulation formulations of poorly water-soluble active agents
09/25/2014WO2014152200A1 Methods and devices for preparation of lipid nanoparticles
09/25/2014WO2014152198A1 Heterocyclic compounds and their uses
09/25/2014WO2014152196A1 Pharmaceutical composition of s-ketamine hydrochloride
09/25/2014WO2014152154A1 Aqueous lubricant composition
09/25/2014WO2014152097A1 Silk-based capsules
09/25/2014WO2014152082A1 Process of forming a dissolvable fiber
09/25/2014WO2014152009A1 Transdermal formulations of laquinimod
09/25/2014WO2014152007A1 Films and drug delivery systems for rizatriptan
09/25/2014WO2014151975A1 Film delivery system for active ingredients
09/25/2014WO2014151915A1 Continuous single layer film structure including discrete domains
09/25/2014WO2014151865A1 Methods and materials for detection of biologicals
09/25/2014WO2014151853A1 Methods of treating bladder cancer
09/25/2014WO2014151797A1 Extended release formulations resistant to alcohol dose dumping
09/25/2014WO2014151769A1 Compositions including encapsulated isotretinoin and methods for use thereof
09/25/2014WO2014151768A1 A process for drying a wet film with control of loss on drying
09/25/2014WO2014151752A1 Composition and methods for the treatment of peripheral nerve injury
09/25/2014WO2014151742A1 Formulation containing carbidopa, levodopa, and entacapone
09/25/2014WO2014151725A1 Composition of a sustained-release delivery and method of stabilizing proteins during fabrication process
09/25/2014WO2014151705A1 Methods for preparing injectable protein microparticle suspensions
09/25/2014WO2014151697A1 Therapeutic uses for geranylgeranyl acetone and derivatives thereof
09/25/2014WO2014151654A1 Microarray for delivery of therapeutic agent and methods of use
09/25/2014WO2014151587A2 Amphiphilic resin linear copolymers for pharmaceutical drug delivery applications
09/25/2014WO2014151575A1 Solid oral dosage formulation of hcv inhibitor in the amorphous state
09/25/2014WO2014151565A1 Compounds to modulate intestinal absorption of nutrients
09/25/2014WO2014151547A1 Sovaprevir tablets
09/25/2014WO2014151492A1 Compositions and methods for transdermal delivery of tertiary amine drugs
09/25/2014WO2014151464A1 Film-forming agents formed from silicone pressure sensitive adhesives and silicone acrylic polymers
09/25/2014WO2014151459A1 Aqueous delivery system for low surface energy structures
09/25/2014WO2014151413A2 Fkbp52 targeting agent pharmaceutical compositions
09/25/2014WO2014151396A1 Aqueous delivery system for low surface energy structures
09/25/2014WO2014151387A1 Stable transdermal amphetamine compositions and methods of manufacture
09/25/2014WO2014151381A1 Bioerodible silicon-based compositions for delivery of therapeutic agents
09/25/2014WO2014151329A1 Particles for aerosolizing apparatus
09/25/2014WO2014151109A1 Formulations of water-soluble derivatives of vitamin e and compositions containing same
09/25/2014WO2014150782A1 Ketal adducts, methods of manufacture, and uses thereof
09/25/2014WO2014150660A1 Racecadotril lipid compositions
09/25/2014WO2014150651A1 Racecadotril liquid compositions
09/25/2014WO2014150609A1 Metadichol r liquid and gel nanoparticle formulations
09/25/2014WO2014150343A1 Soft gel encapsulation
09/25/2014WO2014150293A1 Microarray with polymer-free microstructures, methods of making, and methods of use
09/25/2014WO2014150074A1 Compositions and methods for nucleic acid delivery
09/25/2014WO2014150069A1 Microstructure array for delivery of active agents
09/25/2014WO2014149939A1 Dye free liquid therapeutic solution
09/25/2014WO2014149674A1 Controlled release pharmaceutical dosage forms
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 2991